Get More Information on Dose Calibrator Market - Request Sample Report
The Dose Calibrator Market Size was valued at USD 1.5 Billion in 2023 and is expected to reach USD 2.1 Billion by 2032 and grow at a CAGR of 3.9% over the forecast period 2024-2032.
Dose calibrators experience a significantly high demand as healthcare infrastructure develops. One of the drivers for the growing significance of dose calibrators is the growing incorporation of the latest equipment and technologies at healthcare facilities across the world. As many regions experienced substantial investments in healthcare infrastructure, including the construction of new hospitals and the enhancement of diagnostic facilities. For instance, in 2023, the World Health Organization (WHO) reported substantial investments in healthcare infrastructure across various regions, including new hospital construction and the enhancement of diagnostic facilities. This growth is driven by the rising prevalence of chronic diseases and the need for advanced diagnostic and therapeutic solutions.
Moreover, the U.S. Centers for Medicare & Medicaid Services state that the country’s healthcare spending has increased, with particular investments in the diagnostic imaging and radiology departments of the newly erected and remodeled hospitals. These trends are consistent with global tendencies, as many countries are modernizing the existing healthcare facilities to meet the growing demand for advanced medical technologies, including the use of dose calibrator applications.
Another driver of in the dose calibrator market is technological innovations which have improved the precision of measurements and operational adjustments in recent years. It is stated that the advent of more accurate and user-friendly equipment has allowed the industry to change during these last years. As an example, in 2023, Varian Medical Systems released its next-generation automatic dose calibrator, which comes with advanced digital technology, allowing to accommodate the adjustments in measurements in real-time, providing increased frequencies of calibration, and improved accuracy to meet the growing complexity of nuclear medicine and demand in dose.
These technological advancements are contributing to the dose calibrator market's growth by enhancing device performance and ease of use. As healthcare facilities increasingly adopt these advanced technologies, the demand for advanced dose calibrators continues to rise, driving further innovation and market expansion.
Moreover, The U.S. Food and Drug Administration (FDA) has approved several new dose calibrators and related technologies in recent years. In 2024, the FDA issued new guidelines for dose calibrator accuracy and performance, reflecting the emphasis on enhancing precision and safety in medical procedures. These guidelines encourage the adoption of advanced, automated, and digital dose calibration systems.
Drivers
The dose calibrator market is experiencing significant growth due to advances in medical imaging, as well as in nuclear medicine. First and foremost, the increased complexity and sophistication of medical imaging technologies, such as positron emission tomography and single-photon emission computed tomography, require more precise and accurate measurement of radiation doses. This is an essential application of dose calibrators, as these devices allow ensuring that the correct dose of radiopharmaceuticals is administered, which is necessary to achieve accurate diagnostics and treatment.
In 2023, IBA launched the latest edition of its Smartscan system, integrating advanced dose calibrator technology for both imaging and therapeutic applications. This innovation enables healthcare providers to achieve more reliable radiation dose measurements, enhancing safety and efficiency in diagnostic imaging procedures.
Moreover, advances in nuclear medicine have also expanded the need for advanced dose calibrators as they relate to an increased variety and complexity of new radiopharmaceuticals that are being developed. On top of that, as medical treatment becomes more personalized and targeted, the need for very precise and accurate measurements has also increased, fueling the expansion of the market. Finally, regulatory changes and increased emphasis on measures designed to ensure patient safety are driving healthcare facilities to invest in state-of-the-art dial calibration equipment.
In the U.S., medical imaging services, including nuclear medicine procedures, accounted for more than USD 15 billion in healthcare spending, underlining the growing demand for advanced diagnostic technologies. This growth aligns with the increased use of dose calibrators to ensure accurate dosing in radiopharmaceutical therapies.
Restrain
Dose calibrator devices are highly advanced precision instruments designed to measure radioactivity in nuclear medicine applications, ensuring the accurate dosing of radiopharmaceuticals. Even though the dose calibrator is popular in many developed countries, not all healthcare facilities, especially in the developing world, can afford to invest in such a piece of equipment due to a lack of financial resources. Limited budgets make it difficult for many to enter the market, which may be linked to the slower rates of nuclear diagnostic and treatment implementation.
By Type
PET Nuclides held the largest market share around 66.95% in 2023. This is primarily due to the widespread use of Positron Emission Tomography (PET) in nuclear medicine, particularly for oncology, cardiology, and neurology applications. PET imaging offers higher resolution and more precise diagnostic capabilities compared to other imaging techniques, driving its demand in hospitals and diagnostic centers globally. Additionally, advancements in PET technology, such as hybrid PET/CT and PET/MRI systems, have enhanced its utility in medical diagnostics. These innovations have increased the reliance on PET nuclides, thus propelling this segment to lead the market.
Need any customization research on Dose Calibrator Market - Enquiry Now
By Application
Department of Nuclear Medicine segment held the highest market share around 48.23% in 2023. This dominance is primarily due to the widespread application of dose calibrators in nuclear medicine for diagnostic and therapeutic procedures. In nuclear medicine, accurate dosage measurement of radiopharmaceuticals is critical for ensuring patient safety and the effectiveness of treatments. Dose calibrators are integral in determining the exact radioactivity levels to be administered, particularly in procedures like positron emission tomography (PET) and single-photon emission computed tomography.
By Form
Hospitals are the major area for the end-use industry which holds the largest market share in the dose calibrator market. This is because hospitals play an important role for the administration of advanced diagnostic and therapeutic aspects, especially nuclear medicine. Nuclear medicine departments in hospitals have the required building infrastructure. The dose calibrator is needed in the hospital for accurate measurement and administration of radiopharmaceuticals on a patient to cure diseases. As the use of nuclear medicine is growing in the hospital for diagnosing and treating several diseases such as cardiovascular diseases, cancer, and neurological diseases the demand for the dose calibrator is growing in hospitals.
Regional Analysis
North America dominated the dose calibrator market with the highest revenue share of more than 42.40% in 2023. The region’s firmly developed healthcare infrastructure and a high level of investment in all technologies of nuclear medicine require the precise measurement and calibration of radiopharmaceuticals. This position was strengthened by the recent developments. Capintec, one of the leading players in the industry, introduced the Capintec CRC®-15R Dose Calibrator in 2023. The range of advanced technologies used in this calibrator makes it more accurate and efficient in handling radiopharmaceuticals. Besides, in 2022, Biodex Medical Systems released a new version of Atomlab 100 Dose Calibrator, and the improved software used in this device makes it easier to work with and integrate into the applicable medical imaging systems.
Moreover, the region also has a stronger position primarily due to the severe legislative frameworks of the United States and Canada, striving to set the highest standards of radiopharmaceutical practice and sophisticated aid for these medications. The investment in the North American healthcare sector is still significantly larger than in other world regions. Finally, the administration of cancer procedures of treatment and diagnostics is also partially nuclear medicine, which also increases the demand for dose calibrators. Thus, the focus on advanced technology, backed by a perfect environment and the regional med sector’s growth, guarantees North America’s leadership in the field of dose calibrator market.
Key Players
The major players are VacuTec, Esente Healthcare, Radcal, Metrohm, Nuclemed, Pinestar Technology, Siemens Healthineers, Capintec, Thermo Fisher Scientific, Biodex Atomlab, and other players
In 2023, Capintec introduced the Capintec CRC®-15R Dose Calibrator, which features enhanced digital technology for superior accuracy and user-friendly operation.
In 2022, Biodex Medical Systems launched the Atomlab 100 Dose Calibrator. This updated model includes advanced software integration that streamlines the calibration process and enhances accuracy.
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.5 Billion |
| Market Size by 2032 | US$ 2.1 Billion |
| CAGR | CAGR of 3.9% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (RSO Nuclides, PET Nuclides) • By Application (Department of Nuclear Medicine, Radiochemistry Center, Others) • By End-User, (Hospitals, Radiology Clinics, Nuclear Medicine centers, and Veterinary Clinics) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | VacuTec, Esente Healthcare, Radcal, Metrohm, Nuclemed, Pinestar Technology, Siemens Healthineers, Capintec, Thermo Fisher Scientific, Biodex Atomlab, and other players |
| Key Drivers | •Advancements in medical imaging and nuclear medicine drive the market growth. |
| RESTRAINTS | •High equipment cost hampers market growth. |
Ans. The projected market size for the Dose Calibrator Market is USD 2.10 billion by 2032.
Ans: The Hospital end-user segment dominated the Dose Calibrator Market.
Ans: The North American region dominated the Dose Calibrator Market in 2023, with a 42.40% share.
Ans. The CAGR of the Dose Calibrator Market is 3.9% During the forecast period of 2024-2032.
Ans: Yes, you can customize the report as per your requirements.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Vaccines & Therapeutics Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Type Benchmarking
6.3.1 Type specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Dose Calibrator Market Segmentation, by Type
7.1 Chapter Overview
7.2 RSO Nuclides
7.2.1 RSO Nuclides Market Trends Analysis (2020-2032)
7.2.2 RSO Nuclides Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 PET Nuclides
7.3.1 PET Nuclides Market Trends Analysis (2020-2032)
7.3.2 PET Nuclides Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Dose Calibrator Market Segmentation, by Application
8.1 Chapter Overview
8.2 Department of Nuclear Medicine
8.2.1 Department of Nuclear Medicine Market Trends Analysis (2020-2032)
8.2.2 Department of Nuclear Medicine Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Radiochemistry Center
8.3.1 Radiochemistry Center Types Market Trends Analysis (2020-2032)
8.3.2 Radiochemistry Center Types Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Dose Calibrator Market Segmentation, by End-User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Radiology Clinics
9.3.1 Radiology Clinics Market Trends Analysis (2020-2032)
9.3.2 Radiology Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Nuclear Medicine Centers
9.4.1 Nuclear Medicine Centers Market Trends Analysis (2020-2032)
9.4.2 Nuclear Medicine Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Veterinary Clinics
9.5.1 Veterinary Clinics Market Trends Analysis (2020-2032)
9.5.2 Veterinary Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Dose Calibrator Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Dose Calibrator Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Dose Calibrator Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Dose Calibrator Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Dose Calibrator Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Dose Calibrator Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Dose Calibrator Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Dose Calibrator Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Dose Calibrator Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Dose Calibrator Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11. Company Profiles
11.1 VacuTec
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Types/ Services Offered
11.1.4 SWOT Analysis
11.2 Esente Healthcare
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Types/ Services Offered
11.2.4 SWOT Analysis
11.3 Radcal
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Types/ Services Offered
11.3.4 SWOT Analysis
11.4 Metrohm
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Types/ Services Offered
11.4.4 SWOT Analysis
11.5 Nuclemed
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Types/ Services Offered
11.5.4 SWOT Analysis
11.6 Pinestar Technology
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Types/ Services Offered
11.6.4 SWOT Analysis
11.7 Siemens Healthineers
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Types/ Services Offered
11.7.4 SWOT Analysis
11.8 Capintec
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Types/ Services Offered
11.8.4 SWOT Analysis
11.9 Thermo Fisher Scientific
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Types/ Services Offered
11.9.4 SWOT Analysis
11.10 Biodex Atomlab
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Types/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Type
RSO Nuclides
PET Nuclides
By Application
Department of Nuclear Medicine
Radiochemistry Center
Others
By End-User
Hospitals
Radiology Clinics
Nuclear Medicine Centers
Veterinary Clinics
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Autoimmune Disease Testing Market size was valued at USD 11.24 billion in 2023 and it is expected to be worth around USD 24.14 billion by 2031 growing at a remarkable CAGR of 10.27% over the forecast period 2024-2031.
The eClinical Solutions Market Size was valued at USD 8.33 billion in 2022 and is expected to reach USD 22.94 billion by 2030 and grow at a CAGR of 13.5% over the forecast period 2023-2030.
The Medical Marijuana Market size was valued at USD 16.68 Bn in 2023 and is expected to reach USD 98.47 Bn by 2032 with a growing CAGR of 21.81% over the forecast period of 2024-2032.
The PET Scanners Market Size was valued at USD 2.6 Billion in 2023, and is expected to reach USD 4.9 Billion by 2032, and grow at a CAGR of 7.7%.
The Insomnia Therapeutics Market size was valued at USD 2.50 Billion in 2023 and is expected to reach USD 3.71 Billion by 2032 and grow at a CAGR of 4.53% over the forecast period 2024-2032.
The Nasal Drug Delivery Market was estimated at USD 76.85 billion in 2023 and is poised to reach 137.06 billion in 2031 anticipated to expand at a compound annual growth rate approx. CAGR of 7.5% for the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
